SEC Filings | Celldex Therapeutics

Form	Description	Filing date	View
DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	Nov 6, 2009	View HTML 0001047469-09-009714.pdf 0001047469-09-009714.rtf 0001047469-09-009714.xls
10-Q	Quarterly report which provides a continuing view of a company's financial position	Nov 6, 2009	View HTML 0001104659-09-063266.pdf 0001104659-09-063266.rtf 0001104659-09-063266.xls
8-K	Report of unscheduled material events or corporate event	Nov 4, 2009	View HTML 0001157523-09-007639.pdf 0001157523-09-007639.rtf 0001157523-09-007639.xls
424B2	Form of prospectus filed in connection with primary offering of securities on a delayed basis	Oct 30, 2009	View HTML 0001104659-09-061465.pdf 0001104659-09-061465.rtf 0001104659-09-061465.xls
EFFECT	EFFECT	Oct 30, 2009	View HTML 9999999995-09-003006.pdf 9999999995-09-003006.rtf 9999999995-09-003006.xls
CORRESP	CORRESP	Oct 29, 2009	View HTML 0001104659-09-061182.pdf 0001104659-09-061182.rtf 0001104659-09-061182.xls
S-3/A	Pre-effective amendment to an S-3 filing	Oct 28, 2009	View HTML 0001104659-09-060916.pdf 0001104659-09-060916.rtf 0001104659-09-060916.xls
UPLOAD	UPLOAD	Oct 27, 2009	View HTML 0000000000-09-060641.pdf
S-3	Simplified registration form	Oct 21, 2009	View HTML 0001104659-09-059804.pdf 0001104659-09-059804.rtf 0001104659-09-059804.xls
8-K/A	Amendment to a previously filed 8-K	Oct 21, 2009	View HTML 0001047469-09-009091.pdf 0001047469-09-009091.rtf 0001047469-09-009091.xls

Data provided by Kaleidoscope.